BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 19436109)

  • 21. STAT1 deficiency redirects IFN signalling toward suppression of TLR response through a feedback activation of STAT3.
    Kim HS; Kim DC; Kim HM; Kwon HJ; Kwon SJ; Kang SJ; Kim SC; Choi GE
    Sci Rep; 2015 Aug; 5():13414. PubMed ID: 26299368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The type I interferon-alpha mediates a more severe neurological disease in the absence of the canonical signaling molecule interferon regulatory factor 9.
    Hofer MJ; Li W; Lim SL; Campbell IL
    J Neurosci; 2010 Jan; 30(3):1149-57. PubMed ID: 20089923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic and Functional Identifying of Novel STAT1 Loss-of-Function Mutations in Patients with Diverse Clinical Phenotypes.
    Chen X; Chen J; Chen R; Mou H; Sun G; Yang L; Jia Y; Zhao Q; Wen W; Zhou L; Ding Y; Tang X; Yang J; An Y; Zhao X
    J Clin Immunol; 2022 Nov; 42(8):1778-1794. PubMed ID: 35976469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two novel STAT1 mutations cause Mendelian susceptibility to mycobacterial disease.
    Liu Z; Zhou M; Yuan C; Ni Z; Liu W; Tan Y; Zhang D; Zhou X; Zou T; Wang J; Hou M; Peng X; Zhang X
    Biochem Biophys Res Commun; 2022 Feb; 591():124-129. PubMed ID: 34815077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term Survival After Hematopoietic Stem Cell Transplantation for Complete STAT1 Deficiency.
    Naviglio S; Soncini E; Vairo D; Lanfranchi A; Badolato R; Porta F
    J Clin Immunol; 2017 Oct; 37(7):701-706. PubMed ID: 28815344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient iPSC-Derived Macrophages to Study Inborn Errors of the IFN-γ Responsive Pathway.
    Haake K; Neehus AL; Buchegger T; Kühnel MP; Blank P; Philipp F; Oleaga-Quintas C; Schulz A; Grimley M; Goethe R; Jonigk D; Kalinke U; Boisson-Dupuis S; Casanova JL; Bustamante J; Lachmann N
    Cells; 2020 Feb; 9(2):. PubMed ID: 32093117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic, Immunological, and Clinical Features of 32 Patients with Autosomal Recessive STAT1 Deficiency.
    Le Voyer T; Sakata S; Tsumura M; Khan T; Esteve-Sole A; Al-Saud BK; Gungor HE; Taur P; Jeanne-Julien V; Christiansen M; Köhler LM; ElGhazali GE; Rosain J; Nishimura S; Sakura F; Bouaziz M; Oleaga-Quintas C; Nieto-Patlán A; Deyà-Martinez À; Altuner Torun Y; Neehus AL; Roynard M; Bozdemir SE; Al Kaabi N; Al Hassani M; Mersiyanova I; Rozenberg F; Speckmann C; Hainmann I; Hauck F; Alzahrani MH; Alhajjar SH; Al-Muhsen S; Cole T; Fuleihan R; Arkwright PD; Badolato R; Alsina L; Abel L; Desai M; Al-Mousa H; Shcherbina A; Marr N; Boisson-Dupuis S; Casanova JL; Okada S; Bustamante J
    J Immunol; 2021 Jul; 207(1):133-152. PubMed ID: 34183371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural Basis of the Inhibition of STAT1 Activity by Sendai Virus C Protein.
    Oda K; Matoba Y; Irie T; Kawabata R; Fukushi M; Sugiyama M; Sakaguchi T
    J Virol; 2015 Nov; 89(22):11487-99. PubMed ID: 26339056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inborn errors of STAT1 immunity.
    Mizoguchi Y; Okada S
    Curr Opin Immunol; 2021 Oct; 72():59-64. PubMed ID: 33839590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-inhibition of interferon-induced signals by GM-CSF through a block in Stat1 activation.
    Kasper S; Kindler T; Sonnenschein S; Breitenbuecher F; Böhmer FD; Huber C; Fischer T
    J Interferon Cytokine Res; 2007 Nov; 27(11):947-59. PubMed ID: 18052729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells.
    Miyagi T; Gil MP; Wang X; Louten J; Chu WM; Biron CA
    J Exp Med; 2007 Oct; 204(10):2383-96. PubMed ID: 17846149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Taenia crassiceps infection and its excreted/secreted products inhibit STAT1 activation in response to IFN-γ.
    Becerra-Díaz M; Terrazas LI
    Int J Parasitol; 2014 Aug; 44(9):613-23. PubMed ID: 24837622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Complete Autosomal-Recessive STAT1 LOF Variant Causes Immunodeficiency with Hemophagocytic Lymphohistiocytosis-Like Hyperinflammation.
    Boehmer DFR; Koehler LM; Magg T; Metzger P; Rohlfs M; Ahlfeld J; Rack-Hoch A; Reiter K; Albert MH; Endres S; Rothenfusser S; Klein C; Koenig LM; Hauck F
    J Allergy Clin Immunol Pract; 2020 Oct; 8(9):3102-3111. PubMed ID: 32603902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined novel homozygous variants in both
    Roa-Bautista A; Sohail M; Wakeling E; Gilmour KC; Davis M; Gait A; Lucchini G; Cox D; Elfeky R; Kusters M
    Front Immunol; 2023; 14():1186575. PubMed ID: 37377976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokine-stimulated GTP cyclohydrolase I expression in endothelial cells requires coordinated activation of nuclear factor-kappaB and Stat1/Stat3.
    Huang A; Zhang YY; Chen K; Hatakeyama K; Keaney JF
    Circ Res; 2005 Feb; 96(2):164-71. PubMed ID: 15604419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox.
    Nguyen KB; Cousens LP; Doughty LA; Pien GC; Durbin JE; Biron CA
    Nat Immunol; 2000 Jul; 1(1):70-6. PubMed ID: 10881178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The
    Hagberg N; Joelsson M; Leonard D; Reid S; Eloranta ML; Mo J; Nilsson MK; Syvänen AC; Bryceson YT; Rönnblom L
    Ann Rheum Dis; 2018 Jul; 77(7):1070-1077. PubMed ID: 29475858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracellular bacterial infection-induced IFN-gamma is critically but not solely dependent on Toll-like receptor 4-myeloid differentiation factor 88-IFN-alpha beta-STAT1 signaling.
    Rothfuchs AG; Trumstedt C; Wigzell H; Rottenberg ME
    J Immunol; 2004 May; 172(10):6345-53. PubMed ID: 15128825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of alpha/beta and gamma interferons.
    Andrejeva J; Young DF; Goodbourn S; Randall RE
    J Virol; 2002 Mar; 76(5):2159-67. PubMed ID: 11836393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
    Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL
    Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.